Yarlagadda S Babu is Chief Discovery Officer of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 298,541 shares of BCRX, which is worth approximately $2.15 Million. The most recent transaction as insider was on Nov 14, 2022, when has been sold 31,515 shares (Common Stock) at a price of $13.88 per share, resulting in proceeds of $437,428. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 299K
0% 3M change
0% 12M change
Total Value Held $2.15 Million

Yarlagadda S Babu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 14 2022
SELL
Open market or private sale
$437,428 $13.88 p/Share
31,515 Reduced 9.55%
298,541 Common Stock
Nov 14 2022
BUY
Exercise of conversion of derivative security
$142,000 $1.42 p/Share
100,000 Added 23.25%
330,056 Common Stock
Mar 07 2022
SELL
Open market or private sale
$343,200 $17.16 p/Share
20,000 Reduced 8.0%
230,056 Common Stock
Dec 14 2021
BUY
Grant, award, or other acquisition
-
35,000 Added 12.28%
250,056 Common Stock
Dec 07 2021
SELL
Open market or private sale
$367,220 $12.2 p/Share
30,100 Reduced 12.28%
215,056 Common Stock
Dec 07 2021
BUY
Exercise of conversion of derivative security
$293,260 $4.73 p/Share
62,000 Added 20.19%
245,156 Common Stock
Feb 19 2021
SELL
Payment of exercise price or tax liability
$258,629 $11.53 p/Share
22,431 Reduced 10.91%
183,156 Common Stock
Feb 19 2021
BUY
Exercise of conversion of derivative security
$207,500 $4.15 p/Share
50,000 Added 19.56%
205,587 Common Stock
YSB

Yarlagadda S Babu

Chief Discovery Officer
Durham, NC

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX